E

Bridging the gap between AACR and ASCO

Segueing between preclinical and clinical data

April 25, 2024
E

The perils of misreading oncogenic signalling

Finding the right cell/right compartment isn't easy - it requires persistence and dedication

February 13, 2024
E

An emerging new target for ER positive breast cancer

Hats off to companies pursuing an emerging target in breast cancer

December 19, 2023
E

The weird, the wild, and the wonderful

A discussion of some of the key topics emerging in ER+ HER2- breast cancer

May 15, 2023
E
The key to success in TPD

AACR23 Preview 8 – Keys to success in TPD

W2W4 on the TPD front

April 14, 2023
E

ESMO22 Preview 1 – what to watch out for in breast cancer

Review of some of the key trials in breast cancer being showcased in Paris next month

August 22, 2022
E

ESMO21 Highlights from Day 1

Key posters of interest at ESMO21

September 17, 2021
E

AACR Preview 2 – Pathways to Success in Targeted Therapies

A look at a wide array of targets, modalities, new agents and companies through the lens of targeted therapies

April 16, 2020